Capecitabine in patients with breast cancer relapsing after high-dose chemotherapy plus autologous peripheral stem cell transplantation - A phase II study

Anti-Cancer Drugs

Volumn 13, Issue 4, 2002, Pages 405-410

  Jakob, A ^a   Bokemeyer, Carsten ^a   Knop, S ^a   Schupp, M ^a   Mayer, F ^a   Kanz, L ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Anthracycline resistance; Breast cancer; Capecitabine; Oral chemotherapy; Peripheral blood stem cell transplantation; Taxane resistance

Indexed keywords

ANTHRACYCLINE; CAPECITABINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; TAXANE DERIVATIVE; THIOTEPA;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DISEASE COURSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEVER; GRANULOCYTOPENIA; HAND FOOT SYNDROME; HUMAN; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; STEM CELL TRANSPLANTATION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DISEASE PROGRESSION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0036234330     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200204000-00009     Document Type: Article

References (13)

1. Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts
2. New developments in angiogenesis: A major mechanism for tumor growth and target for therapy
3. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue
4. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study
5. The role of capecitabine, an oral, enzymatically activated fluoropyrimidine, in the treatment of metastatic breast cancer
6. Oral fluoropyrimidines among the new drugs for patients with metastatic breast cancer
7. Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer
8. The determination of the number of patients required in a follow-up trial of a new chemotherapeutic agent
9. The use of the nitrogen mustards in the palliative treatment of carcinoma, with particular reference to bronchogenic carcinoma
10. Chemotherapy for advanced disease
11. Phase I/II study of a weekly 24-hour infusion of 5-fluorouracil plus high dose folinic acid (HD-5FU/FA) in intensively treated patients with metastatic breast cancer
12. Oral capecitabine is an active and well tolerated primary palliative treatment in patients with metastatic breast cancer who progress after high-dose chemotherapy and autologous stem cell support